Board of
Directors 

Nancy Dunlap

Capson Board Member

Capson

Capson’s Board of Directors includes esteemed representatives from both the medical malpractice and healthcare industries. Our board members are visionaries and innovators who are passionate about our mission and vision to transform the landscape of medical malpractice insurance. The board meets four times per year to review Capson’s activities and provide guidance and strategic planning. Our directors and their areas of expertise are provided below.


DOWNES.png

Matt Downs

Matt Downs is a Managing Director of Sandbox Industries. He oversees Sandbox’s investments covering agriculture, healthcare, and technology. Matt co-founded Sandbox’s first collaborative investment vehicle, BlueCross BlueShield Venture Partners, L.P., which, together with its successor fund, has $305 million in capital commitments. He helped start and then served as a board member of Bloom Health, which was acquired by three BlueCross BlueShield Health Plans. He also led the investment in Initiate Systems, which was acquired by IBM. Matt currently serves on the boards of Essence Health Group, Myca Health Inc., Medsave, and Capson. He holds a B.A. from Brigham Young University and an M.B.A. from the Stanford Graduate School of Business.

COLOSKY.png
 

Douglas Colosky

Doug is Head of US Operations for Beazley and a member of the US Management Committee. Prior to his current position, Doug served as the Underwriting Manager for Specialty Lines and as a member of the Specialty Lines Management team. Beazley plc is a specialist insurance business with operations in Europe, the U.S., Asia, and Australia. Beazley manages five of Lloyd’s syndicates. Prior to joining Beazley in 2005, Doug spent five years with Travelers in various claim and underwriting capacities.


FOSTER.png

Jon M. Foster

Jon is President of a regional group of facilities for Hospital Corporation of America, better known as HCA. He oversees 52,000 employees and 47 hospitals in Texas, Oklahoma, Colorado, and Kansas. The group has annual revenue of $11 billion. For the prior 10 years, Jon led St. David’s Healthcare, a $3 billion, six-hospital healthcare system with 21 locations throughout Central Texas. Jon shares his insights, gained from over 24 years of experience in healthcare and hospital administration, with Capson.


DUNLAP.png

Nancy Dunlap

Nancy previously served on the Board of Directors of St. Luke’s Episcopal Hospital in Houston, a 912-bed hospital located in the Texas Medical Center, and chairs the Joint Conference Committee. Nancy served for nine years on the board of directors of St. Luke’s Episcopal Health System – a multi-hospital system that includes the Texas Heart Institute at the flagship St. Luke’s Episcopal Hospital. Nancy’s extensive hospital management experience is invaluable to the Capson board.


DIECK.png

John A. Dieck, M.D.

Dr. Dieck is a cardiologist and has been in private practice in Austin since 1990. During this time, he has served as the Chief of Catheterization Laboratories for Seton Medical Center, St. David’s Episcopal Hospital, South Austin Medical Center, and as the Director of Heart Failure and Cardiac Transplantation at Seton Medical Center. Dr. Dieck shares with Capson his perspective as a practicing physician.


RICE.png

William H. Rice, M.D.

Dr. Rice is the Senior Vice President of Clinical Innovation for St. David’s HealthCare. Prior to assuming this role, he served as Chief Medical Officer of Whiteglove House Call Health, a company he co-founded. Prior to that, Dr. Rice was the first full-time physician involved in the development of RevolutionHealth, a leading consumer-centric health company founded to transform how people approach their overall health and wellness. In addition to his 14 years of experience in clinical emergency medicine, Dr. Rice has participated in the formation and initial work of a number of early-stage healthcare companies. As the founding chairman and Chief Executive Officer of Stat Healthcare, he built one of the largest physician management companies in the United States and managed the business from inception to public offering. Dr. Rice holds a patent for a system and method to optimize the care of chronic disease patients. He is the author of a book titled American Healthcare 2008, Opportunities for Disruptive Improvement.